NIAID awards $1.4M for further development of HIV assay

07/23/2013 | Genetic Engineering & Biotechnology News

MBio Diagnostics landed a two-year, $1.4 million grant from the National Institute of Allergy and Infectious Diseases for the next development phase of a low-cost, point-of-care HIV antigen/antibody diagnostic test. Infectious disease specialists at the University of California, San Diego, are assisting with development. The company's pipeline includes diagnostics for tuberculosis and the hepatitis C virus.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA